newsfilter
← Latest News
GlobeNewswire·

Olema Oncology Reports Second Quarter 2026 Financial and Operating Results

Completed enrollment in the pivotal Phase 3 OPERA-01 trial; top-line data are now expected in the first quarter of 2027Presented initial Phase 1 clinical data for OP-3136 at the 2026 ASCO Annual MeetingAnnounced a